Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00100854
Status:
COMPLETED
Last Update Posted:
2019-03-05
First Post:
2005-01-06
Brief Title:
Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Translational Oncology Research International
Organization:
Translational Oncology Research International
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-10-28
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-09-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-01-06
First Submit QC Date:
January 6 2005
Study First Post Date:
2005-01-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-01
Last Update Post Date:
2019-03-05
Last Update Post Date Type:
ACTUAL